Espee Global Clinical Trial Services Private Limited - Company Profile

It is a business services private limited company based in Ahmadabad City, Gujarat, India, established in 2025.
2025 Ahmadabad City, Gujarat, India Active
Last Updated:
Access Report
About Espee Global Clinical Trial Services Private Limited

Espee Global Clinical Trial Services Private Limited, a active private limited company, was established on 24 July 2025 in Ahmadabad City, Gujarat, India. it holds CIN: U74909GJ2025PTC165441. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 M.

Formerly known as Espee Global Clinical Trial Services Private Limited. Its leadership includes Anar Swapnil Shah (Director), Vishrut Chandramauli Pathak (Director), Pratik Sureshkumar Thakkar (Director). Past directors included Daljit Kaur, Swapnil Jatinbhai Shah, Roma Vinodbhai Shah. It is based at 1101 To 1103, 11Th Floor, South Tower, One 42, Ahmadabad City, Gujarat, 380054.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74909GJ2025PTC165441

  • Registration Number

    165441

  • Incorporation Date

    24 July 2025

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 1.00 M
  • Company Age 7 Months 3 Days
Company report

Espee Global Clinical Trial Services Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Espee Global Clinical Trial Services Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Espee Global Clinical Trial Services Private Limited?
Current Directors
Name Designation Appointment Date Status
Anar Swapnil Shah Director 24 Jul 2025 Current
Vishrut Chandramauli Pathak Director 24 Jul 2025 Current
Pratik Sureshkumar Thakkar Director 24 Jul 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Individual Subscriber - Past
Pramod Abcsdd Non- Individual Subscriber - Past
Pramod Abcsdd Individual Subscriber - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Espee Global Clinical Trial Services.
Espee Global Clinical Trial Services revenue growth over time
Espee Global Clinical Trial Services profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Espee Global Clinical Trial Services?

Unlock access to Espee Global Clinical Trial Services's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Espee Global Clinical Trial Services?

Unlock and access historical data on people associated with Espee Global Clinical Trial Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Espee Global Clinical Trial Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Espee Global Clinical Trial Services's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Espee Global Clinical Trial Services
Recent Activity within the Organization
  • Director Appointment

    Anar Swapnil Shah was appointed as a Director was appointed as a Director on 24 Jul 2025 & has been associated with this company since 7 months 3 days . was recorded as a recent event.

  • Director Appointment

    Vishrut Chandramauli Pathak was appointed as a Director was appointed as a Director on 24 Jul 2025 & has been associated with this company since 7 months 3 days . was recorded as a recent event.

  • Director Appointment

    Pratik Sureshkumar Thakkar was appointed as a Director was appointed as a Director on 24 Jul 2025 & has been associated with this company since 7 months 3 days . was recorded as a recent event.

  • Company Incorporation

    Progress on Espee Global Clinical Trial Services Private Limited was registered on 24 Jul 2025 with Roc Ahmedabad & aged 7 months 3 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Espee Global Clinical Trial Services Private Limited?

The CIN of Espee Global Clinical Trial Services Private Limited is U74909GJ2025PTC165441.

Where is Espee Global Clinical Trial Services Private Limited headquartered?

Espee Global Clinical Trial Services Private Limited is headquartered at 1101 To 1103, 11Th Floor, South Tower, One 42, Ahmadabad City, Gujarat, 380054.

When was Espee Global Clinical Trial Services Private Limited incorporated?

Espee Global Clinical Trial Services Private Limited was incorporated on 24 July 2025.

Who are the current directors of Espee Global Clinical Trial Services Private Limited?

The current directors of Espee Global Clinical Trial Services Private Limited are

Is Espee Global Clinical Trial Services Private Limited a listed company?

Espee Global Clinical Trial Services Private Limited is unlisted.

What is the capital structure of Espee Global Clinical Trial Services Private Limited?

The authorized capital of Espee Global Clinical Trial Services Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available